Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9.

导出 LinkOut

翻译打印收藏纠错

作者： Jame,Abraham ^[1] ; André,Robidoux ; Antoinette R,Tan ; Steven,Limentani ; Keren,Sturtz ; Ibrahim,Shalaby ; Hope,Alcorn ; Marc E,Buyse ; Norman,Wolmark ; Samuel A,Jacobs

作者单位： NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center, 12th Flr., Pittsburgh, PA, 15212, USA. ^[1]

主题词成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);环磷酰胺(Cyclophosphamide);多柔比星(Doxorubicin);用药计划表(Drug Administration Schedule);女(雌)性(Female);人类(Humans);服药依从性(Medication Adherence);中年人(Middle Aged);肿瘤辅助疗法(Neoadjuvant Therapy);肿瘤分期(Neoplasm Staging);紫杉酚(Paclitaxel);治疗结果(Treatment Outcome)

DOI 10.1007/s10549-015-3466-4

PMID 26126970

发布时间 2016-06-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览25

Breast cancer research and treatment

2015年152卷2期

399-405页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9.

Breast cancer research and treatment

相似文献

Breast cancer research and treatment

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9.

Breast cancer research and treatment

相似文献

Breast cancer research and treatment

相关期刊

检索历史清除